Ordaos

Ordaos is a company headquartered in the United States.

Ordaos develops AI-driven de novo designed mini-proteins and single domain antibodies to accelerate the creation of novel therapies for drug discovery, focusing on safer, more effective protein therapeutics that are easier to manufacture.